A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

NCT03331562 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Pancreas Adenocarcinoma
Advanced Pancreatic Cancer
Metastatic Pancreatic Cancer
Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: Pembrolizumab
DRUG: paricalcitol
DRUG: placebo

Sponsor

Translational Genomics Research Institute

Collaborators

[object Object]
[object Object]